Cytosorbents (CTSO) Misses Q2 EPS by 12c

Cytosorbents (NASDAQ: CTSO) reported Q2 EPS of ($0.25), $0.12 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.5 million versus the consensus estimate of $9.58 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• Alpine Income Property Trust, Inc. (PINE) Tops Q2 EPS by 2c; Offers Guidance
• American Business Bank (AMBZ) Tops Q2 EPS by 177c